Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Evaluation of Use Sodic Enoxaparin
This study has been completed.
Study NCT00673426   Information provided by L.A.L Clinica Pesquisa e Desenvolvimento Ltda.

First Received on May 5, 2008.   Last Updated on May 6, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
Enoxaparin sodic
Additional drug interventions recognized in this trial
Enoxaparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services